Chicago Public Schools, the nation's third largest school district, canceled instruction on Friday for the third day in a row amid an impasse over in-person learning.

Classes were first canceled Wednesday, and then again on Thursday, after a majority of the Chicago Teachers Union's membership voted this week in favor of remote learning during a surge in COVID-19 cases.

The district said Thursday evening that all classes will be canceled on Friday, though some schools may be able to offer in-person activities for students.

"Our schools are the best, safest place for students to be during this pandemic, and we are working tirelessly to get everyone back in class every day," Pedro Martinez, head of the school district, said in a letter to families, noting that they are continuing to work with the union "to resolve this situation."

The teacher's union is calling for more robust school COVID-19 testing and contact tracing.

Johnson & Johnson's single-shot COVID-19 vaccine offers lower initial efficacy compared to Pfizer's and Moderna's, but protection against breakthrough infection remains more stable over time, according to a new study sponsored by the pharmaceutical company.

The study found that the J&J vaccine was 74% effective against breakthrough infection in the weeks following the shot. This level of protection held steady over the next three months and started waning after the fourth month.

The Pfizer and Moderna vaccines, meanwhile, were 88% and 92% effective, respectively, against breakthrough infection in the weeks following the second dose, the study found. This level of protection started waning after the second month, falling progressively over six months.

Protection against severe illness remained more stable over time for all three vaccines.

The analysis, which has not been peer-reviewed, looked at data from 168 million people between Jan. 1 and Sept. 7 of last year. It covers a period of alpha and delta variant dominance, but the results could change now that the omicron variant is also present.

The data supports current guidance from the Centers for Disease Control and Prevention for booster shots after two months for the J&J vaccine to bring initial efficacy higher, and booster shots for Pfizer and Moderna vaccines after five and six months, respectively, to boost efficacy after a period of waning.

-ABC News' Sony Salzman

COVID-19 vaccines dramatically reduce the risk of severe illness and death from the virus, according to a new study from the Centers for Disease Control and Prevention published Thursday.

The study looked at 1.2 million fully vaccinated adults who received either two shots of the Pfizer-BioNTech or Moderna vaccines or one shot of the Johnson & Johnson vaccine.

Just 0.18% of patients had breakthrough COVID-19 infections, and 0.015% developed serious illness that led to hospitalization, ICU admission, mechanical ventilation, intubation or death.

The small portion of people who did become seriously sick or die of COVID-19 after being vaccinated were primarily older adults, immunocompromised people or those living with multiple underlying medical conditions.

The study was conducted before the emergence of the omicron variant, which appears to more easily evade --- at least partially -- the protection offered by vaccines.

-ABC News' Sony Salzman

An estimated 126,000 Americans are currently hospitalized with COVID-19, according to new data from the U.S. Department of Health and Human Services.

Of those patients, about one-sixth -- or 21,000 -- are in intensive care units.

The spread of the omicron variant is pushing the U.S. closer to the hospitalization record set last winter when 140,000 patients with the virus were hospitalized .

Meanwhile, the country is averaging 554,000 new COVID-19 cases every day, a five-fold increase from a month ago, federal data shows.

Over the last week, the U.S. has reported about 3.88 million COVID-19 infections, which averages out to about six Americans testing positive every second.

-ABC News' Arielle Mitropoulos

The American Medical Association, the nation’s largest association of physicians, has criticized the Centers for Disease Control and Prevention's new quarantine and isolation guidance for COVID-19, saying the recommendations "are risking further spread of the virus."

The CDC updated its guidelines on Dec. 27, saying asymptomatic people who test positive for COVID-19 should self-isolate for five days rather than 10.

"The American people should be able to count on the Centers for Disease Control and Prevention (CDC) for timely, accurate, clear guidance to protect themselves, their loved ones, and their communities. Instead, the new recommendations on quarantine and isolation are not only confusing, but are risking further spread of the virus," the American Medical Association's president, Dr. Gerald E. Harmon, said in a statement Wednesday night.

Harmon referenced data cited by the CDC in its rationale for shortening the isolation period, which estimates 31% of people remain infectious five days after a positive COVID-19 test, suggesting that data proves thousands of Americans could return to their lives while still infected.

"With hundreds of thousands of new cases daily and more than a million positive reported cases on January 3, tens of thousands -- potentially hundreds of thousands of people -- could return to work and school infectious if they follow the CDC’s new guidance on ending isolation after five days without a negative test," Harmon said. "Physicians are concerned that these recommendations put our patients at risk and could further overwhelm our health care system."

Harmon said a negative COVID-19 test should be required for ending isolation after a positive test, as reentering society without knowing whether an individual is still positive ultimately risks further transmission of the virus.

Although test availability remains an issue nationwide, Harmon also called on the Biden administration to ramp up production and distribution of tests, adding that "a dearth of tests at the moment does not justify omitting a testing requirement to exit a now shortened isolation."

-ABC News' Arielle Mitropoulos